1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Generic Markets 20 APRIL 2015

World Generic Markets 20 APRIL 2015

  • April 2015
  • -
  • Espicom Business Intelligence
  • -
  • 28 pages

Industry Trend Analysis - Teva's Proposed Acquisition Of Mylan Will Reshape The Generic Industry
Industry Brief - Hospira's Infliximab Launched In Canada
Industry Brief - Biocon Gains Mexico Insulin Glargine Approval
Industry Brief - Hi-Tech To Acquire APN
Industry Brief - ANI Launches Propafenone In US
Industry Brief - Companies Gain US Amlodipine+Valsartan Approvals
Industry Brief - TMC Settles Bivalirudin Litigation With Sun
Industry Brief - Aurobindo Gains US Atracurium Approvals
Industry Brief - Aurobindo Gains US Sildenafil Approval
Industry Brief - Actavis Initiates Ambrisentan Patent Challenge
Industry Brief - Sagent Launches Vancomycin In US
Industry Brief - Mylan Settles Sildenafil Citrate Patent Litigation In US
Industry Trend Analysis - Litigation Settlement Proves Viability Of Gralise Business Model
Industry Trend Analysis - First Generic Copaxone Approved But Launch Remains Uncertain
Industry Brief - Perrigo Gains US Triamcinolone Topical Aerosol Approval
Industry Brief - Mylan Gains Appellate Court Victory In Formoterol Inhalation Litigation
Industry Trend Analysis - Patent Challenge Exposes Qsymia's Weaknesses
Industry Brief - EMA Validates Biogen's Infliximab For Review
Industry Trend Analysis - Omega Acquisition Will Establish Perrigo's OTC Dominance
Industry Trend Analysis - Successful Acquisition Of Perrigo Will Boost Mylan's Global Reach And Portfolio
Industry Brief - Consilient Launches Metformin Tablets In UK
Industry Brief - Consilient Announces UK Duloxetine Launch
Industry Trend Analysis - Actavis Acquisition Will Establish A New Regional Presence For Amneal
Industry Brief - Strides Launches Sofosbuvir In India

Table Of Contents

World Generic Markets 20 APRIL 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.